A new study published in the journal eNeuro provides evidence that cannabidiol (CBD), a nonpsychoactive compound derived from cannabis, may help reduce brain inflammation associated with Alzheimer’s ...
FUKUOKA, Japan--(BUSINESS WIRE)--The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens ...
New Findings Support Development of Racemic Tianeptine and (S)-Tianeptine (Estianeptine) as First-in-Class Oral Therapies in Alzheimer’s Disease and Other Psychiatric and Neurodegenerative Conditions ...